Nurix Therapeutics Inc (NRIX) — Cash Flow Reinvestment Rate
Nurix Therapeutics Inc (NRIX) has a Cash Flow Reinvestment Rate of 0.64x as of November 2023, reinvesting $16.96 Million (capex $2.58 Million plus investments $-14.37 Million) from operating cash flow of $26.69 Million. Check NRIX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nurix Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Nurix Therapeutics Inc across 1 annual periods. Explore NRIX long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Nurix Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for Nurix Therapeutics Inc. For live market cap and broader valuation context, see NRIX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 16.89x | $10.15 Million | $601.00K | $1.65 Million | — |